A pleuromutilin derivative containing a 2-thio-4-thiazolidinone side chain, and its preparation method and application
By introducing a 2-thio-4-thiazolidinone structure into the C-14 side chain of pleuromutilin, a new pleuromutilin derivative was synthesized, which solved the problems of cross-resistance of antibacterial drugs and insufficient inhibition of Gram-positive bacteria in the existing technology, and achieved effective inhibition of Staphylococcus aureus and Streptococcus, especially antibacterial activity against MRSA.
Patent Information
- Application Number
- CN202410952695.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2025-09-09
- Estimated Expiration
- 2044-07-16
AI Technical Summary
Existing pleuromutilin compounds have cross-resistance problems among antibacterial drugs and lack effective inhibitory activity against Gram-positive bacteria such as Staphylococcus aureus and Streptococcus.
A new pleuromutilin derivative is synthesized by introducing a 2-thio-4-thiazolidinone structure into the C-14 side chain of pleuromutilin. A compound with good antibacterial activity is obtained through specific synthetic steps including the preparation of intermediates and reaction optimization.
The synthesized truncated pleuromutilin derivatives containing 2-thio-4-thiazolidinone side chains show significant antibacterial activity against Gram-positive bacteria such as Staphylococcus aureus and Streptococcus, and are especially effective against drug-resistant bacteria MRSA, and have good application prospects.